🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Richard J. Lee

Massachusetts General Hospital

ORCID: 0000-0001-9949-671X

Also affiliated with Center for Cancer Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient‐derived primary prostate cells”.

Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient‐derived primary prostate cells

The Prostate(2020)10.1002/pros.24050
N/A
0DataRank · unranked
15 citations

Sivanesan Dakshanamurthy, Henry Walthieu, Erika Parasido, Maria Laura Avantaggiati, Lucas Tricoli +8 more

Outcomes of older men receiving docetaxel for metastatic hormone-sensitive prostate cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.82
N/A
0DataRank · unranked
2 citations

M. Dror Michaelson, Richard J. Lee, Joseph A. Greer, Jennifer S. Temel, Christopher J. Sweeney +1 more

Transforming Potential of Dbl Family Proteins Correlates with Transcription from the Cyclin D1 Promoter but Not with Activation of Jun NH 2 -terminal Kinase, p38/Mpk2, Serum Response Factor, or c-Jun

UNC Libraries(2021)10.17615/qpyq-4m06
N/A
0DataRank · unranked
1 citations

Richard J. Lee, Channing J. Der, Richard G. Pestell, John Westwick, Marc Symons +2 more

Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2972
N/A
0DataRank · unranked
58 citations

Nizar M. Tannir, Othon Iliopoulos, Richard J. Lee, Melinda L. Telli, Alice C. Fan +15 more

Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers

Urologic Clinics of North America(2022)10.1016/j.ucl.2022.09.010
N/A
0DataRank · unranked
8 citations

Richard J. Lee, David T. Miyamoto, Ikenna Madueke

Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0792
N/A
0DataRank · unranked
17 citations

Yuzhen Zhou, Keisuke Otani, Michael Drumm, Yukako Otani, Shulin Wu +17 more

Data from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial

(2023)10.1158/1078-0432.c.6532368.v1
N/A
0DataRank · unranked
0 citations

Nizar M. Tannir, Othon Iliopoulos, Richard J. Lee, Melinda L. Telli, Alice C. Fan +15 more

The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer

Radiotherapy and Oncology(2024)10.1016/j.radonc.2024.110091
N/A
0DataRank · unranked
9 citations

Sergey V. Kozin, Aya Matsui, Saveli Goldberg, Shuichi Aoki, Kohei Shigeta +6 more

Cardiac Structural Changes and Declining Cardiorespiratory Fitness During Androgen Deprivation Therapy for Prostate Cancer

Journal of the American Society of Echocardiography(2024)10.1016/j.echo.2024.03.006
N/A
0DataRank · unranked
1 citations

Matthew R. Smith, M. Dror Michaelson, Richard J. Lee, J. Sawalla Guseh, Meagan M. Wasfy +5 more

Progression-free survival end points in prostate cancer: are we truly making progress

Nature Reviews Urology(2024)10.1038/s41585-024-00902-x
N/A
0DataRank · unranked
1 citations

Edwin M. Posadas, Richard J. Lee, Ravi A. Madan

Restaging With Prostate-Specific Membrane Antigen Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to Care

Journal of Clinical Oncology(2024)10.1200/jco.23.02727
N/A
0DataRank · unranked
5 citations

Evan Y. Yu, Edwin M. Posadas, Richard J. Lee, Fatima Karzai, Peter L. Choyke +1 more

A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer

ESMO Open(2025)10.1016/j.esmoop.2025.104536
N/A
0DataRank · unranked
60 citations

Martin H. Voss, Hussein A. Tawbi, Michael S. Gordon, Scott S. Tykodi, Elaine T. Lam +13 more

Combination Metastasis-Targeted External Beam Radiation Therapy With 177Lu-PSMA-617 in Patients With Advanced Castration-Resistant Prostate Cancer

Practical Radiation Oncology(2025)10.1016/j.prro.2025.03.010
N/A
0DataRank · unranked
5 citations

Isabella R. Pompa, Veronica Haberman, Bashar Kako, Richard J. Lee, Philip J. Saylor +10 more